文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

DARPin诱导人乳头瘤病毒阳性细胞中p53的重新激活。

DARPin-induced reactivation of p53 in HPV-positive cells.

作者信息

Münick Philipp, Strubel Alexander, Balourdas Dimitrios-Ilias, Funk Julianne S, Mernberger Marco, Osterburg Christian, Dreier Birgit, Schaefer Jonas V, Tuppi Marcel, Yüksel Büşra, Schäfer Birgit, Knapp Stefan, Plückthun Andreas, Stiewe Thorsten, Joerger Andreas C, Dötsch Volker

机构信息

Institute of Biophysical Chemistry and Center for Biomolecular Magnetic Resonance, Goethe University, Frankfurt, Germany.

Institute of Pharmaceutical Chemistry, Goethe University, Frankfurt, Germany.

出版信息

Nat Struct Mol Biol. 2025 May;32(5):790-801. doi: 10.1038/s41594-024-01456-7. Epub 2025 Jan 9.


DOI:10.1038/s41594-024-01456-7
PMID:39789211
Abstract

Infection of cells with high-risk strains of the human papillomavirus (HPV) causes cancer in various types of epithelial tissue. HPV infections are responsible for ~4.5% of all cancers worldwide. Tumorigenesis is based on the inactivation of key cellular control mechanisms by the viral proteins E6 and E7. The HPV E6 protein interacts with the cellular E3 ligase E6AP, and this complex binds to the p53 DNA-binding domain, which results in degradation of p53. Inhibition of this interaction has the potential to reactivate p53, thus preventing oncogenic transformation. Here we describe the characterization of a designed ankyrin repeat protein that binds to the same site as the HPV E6 protein, thereby displacing the E3 ligase and stabilizing p53. Interaction with the designed ankyrin repeat protein does not affect p53 DNA binding or the crucial MDM2 negative feedback loop but reactivates a p53-dependent transcriptional program in HeLa (HPV18-positive) and SiHa (HPV16-positive) cells, suggesting a potential therapeutic use.

摘要

人乳头瘤病毒(HPV)高危型毒株感染细胞会在各类上皮组织中引发癌症。HPV感染导致了全球约4.5%的癌症发生。肿瘤发生是基于病毒蛋白E6和E7对关键细胞控制机制的失活作用。HPV E6蛋白与细胞E3连接酶E6AP相互作用,该复合物与p53的DNA结合结构域结合,导致p53降解。抑制这种相互作用有可能重新激活p53,从而防止致癌转化。在此,我们描述了一种设计的锚蛋白重复序列蛋白的特性,该蛋白与HPV E6蛋白结合于同一位点,从而取代E3连接酶并稳定p53。与设计的锚蛋白重复序列蛋白相互作用不会影响p53的DNA结合或关键的MDM2负反馈环,但能在HeLa(HPV18阳性)和SiHa(HPV16阳性)细胞中重新激活p53依赖的转录程序,提示其具有潜在的治疗用途。

相似文献

[1]
DARPin-induced reactivation of p53 in HPV-positive cells.

Nat Struct Mol Biol. 2025-5

[2]
Structure of High-Risk Papillomavirus 31 E6 Oncogenic Protein and Characterization of E6/E6AP/p53 Complex Formation.

J Virol. 2020-12-22

[3]
Identification and characterization of small molecule human papillomavirus E6 inhibitors.

ACS Chem Biol. 2014-6-2

[4]
Quercetin induces G2 phase arrest and apoptosis with the activation of p53 in an E6 expression‑independent manner in HPV‑positive human cervical cancer‑derived cells.

Mol Med Rep. 2019-1-11

[5]
Structure of the E6/E6AP/p53 complex required for HPV-mediated degradation of p53.

Nature. 2016-1-28

[6]
Regulation of human papillomavirus E6 oncoprotein function via a novel ubiquitin ligase FBXO4.

mBio. 2025-2-5

[7]
E6AP is essential for the proliferation of HPV-positive cancer cells by preventing senescence.

PLoS Pathog. 2025-2-7

[8]
E6 proteins from high-risk HPV, low-risk HPV, and animal papillomaviruses activate the Wnt/β-catenin pathway through E6AP-dependent degradation of NHERF1.

PLoS Pathog. 2019-4-19

[9]
In vitro and in vivo growth inhibition of human cervical cancer cells via human papillomavirus E6/E7 mRNAs' cleavage by CRISPR/Cas13a system.

Antiviral Res. 2020-6

[10]
Structure based identification and characterization of flavonoids that disrupt human papillomavirus-16 E6 function.

PLoS One. 2013-12-23

本文引用的文献

[1]
In vivo editing of lung stem cells for durable gene correction in mice.

Science. 2024-6-14

[2]
Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia.

Nature. 2024-4

[3]
Structure of the p53 degradation complex from HPV16.

Nat Commun. 2024-2-28

[4]
DARPins detect the formation of hetero-tetramers of p63 and p73 in epithelial tissues and in squamous cell carcinoma.

Cell Death Dis. 2023-10-12

[5]
Technological advances in the use of viral and non-viral vectors for delivering genetic and non-genetic cargos for cancer therapy.

Drug Deliv Transl Res. 2023-11

[6]
Unlocking the promise of mRNA therapeutics.

Nat Biotechnol. 2022-11

[7]
Designed Ankyrin Repeat Proteins as a tool box for analyzing p63.

Cell Death Differ. 2022-12

[8]
Structural diversity of p63 and p73 isoforms.

Cell Death Differ. 2022-5

[9]
An Update on Human Papilloma Virus Vaccines: History, Types, Protection, and Efficacy.

Front Immunol. 2021

[10]
On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles.

Proc Natl Acad Sci U S A. 2021-12-28

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索